ORGANON (OGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for OGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OGN | Executive Vice President and Chief Financial Officer | 59 | ["Develops and executes Organon's financial strategy","CFO at Allergan plc from 2018 to 2020","CFO at Catalent, Inc. from 2008 to 2018","CFA Charterholder","M.B.A. and bachelor’s degree in chemical engineering from Cornell University"] | ["Audit Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CERT | Executive Vice President and Chief Financial Officer | 59 | ["Executive Vice President and Chief Financial Officer of Organon & Co.", "Former Executive Vice President and Chief Financial Officer of Allergan plc", "Chief Financial Officer of Catalent, Inc.", "President, Chief Financial Officer, and Acting Chief Executive Officer of Escala Group, Inc.", "Experience in global finance, capital markets, operations, and strategic transactions"] | ["Audit (Chair)"] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Walsh is responsible for the development and execution of Organon s financial strategy. He is focused on driving profitability and shareholder value and ensuring the highest standard of financial integrity for Organon so it can reach its vision of becoming a leading women s health company. Over his career, Mr. Walsh has served in several public companies as the CFO and in related roles. Before joining Organon, Mr. Walsh was the Executive Vice President and CFO at Allergan plc, a global pharmaceutical company, from 2018 to 2020, and Catalent, Inc., a global provider of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products from 2008 to 2018, as Senior Vice President from 2008 to 2012 and Executive Vice President from 2012 to 2018. Previously, he held finance and leadership positions at Escala Group and GenTek. Mr. Walsh has also served in corporate development and other roles in the chemical and banking industries. Mr. Walsh is a CFA Charterholder. Since 2020, he has served on the board of directors and as Chair of the Audit Committee of Certara, Inc., a provider of software and consulting services to the life sciences industry, and previously was a board member of Multicolor Corporation, a label solutions provider. Mr. Walsh received an M.B.A. and bachelor s degree in chemical engineering from Cornell University.